Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Clinical trial NCT04254263 · RECRUITING

Trial details

NCT number: NCT04254263
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer

Start date: 2019-12-16
Primary completion: 2026-08-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.